Skip to main content

High-Risk IV Medications in Special Patient Populations

  • Book
  • © 2011

Overview

  • The Institute for Safe Medication Practices has developed a list of high-alert medications which are medications at a heightened risk for patient harm when used in error

  • No book has been published on this topic

  • A resource containing all relevant information at a glance would be time-saving

  • This resource will provide information to those who do not typically have access (community settings)

  • Includes supplementary material: sn.pub/extras

  • 7511 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (8 chapters)

Keywords

About this book

Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions.

Reviews

From the reviews:

“This book reviews the use of intravenous medications in patient populations with special considerations, discussing the dosing guidelines, safety concerns, and monitoring parameters. … It is intended for clinicians treating critically ill patients with high-risk intravenous medications. This is a good reference for doctors, nurses, pharmacists, and students in these disciplines to use to become well versed in the safe use of dangerous medications. … This is an excellent book that provides clear, concise information in a very usable format.”­­­ (Judith Klevan, Doody’s Review Service, November, 2011)

Editors and Affiliations

  • University of Pittsburgh, Pittsburgh, USA

    Sandra Kane-Gill

  • The Ohio State University, Ohio, USA, Round Rock, USA

    Joseph Dasta

Bibliographic Information

  • Book Title: High-Risk IV Medications in Special Patient Populations

  • Editors: Sandra Kane-Gill, Joseph Dasta

  • DOI: https://doi.org/10.1007/978-0-85729-606-1

  • Publisher: Springer London

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer-Verlag London Limited 2011

  • Hardcover ISBN: 978-0-85729-605-4Published: 29 June 2011

  • Softcover ISBN: 978-1-4471-5868-4Published: 15 August 2014

  • eBook ISBN: 978-0-85729-606-1Published: 27 June 2011

  • Edition Number: 1

  • Number of Pages: X, 160

  • Topics: Intensive / Critical Care Medicine, Internal Medicine, Emergency Medicine, Anesthesiology, Pharmacy

Publish with us